Calcium carbonate Tab eff 1.25 g (500 mg elemental): Supply issue

Supply issue Active

Both Cacit brand effervescent tablets (pharmacode 2601036) and the 20 pack of Calcium-Sandoz Forte tablets (pharmacode 2617447) are both out of stock.

Alternative product

From 1 February 2022, we have listed Calcium-Sandoz Forte brand tab eff 1.25 g (500 mg elemental) pack size 100 (pharmacode 2631695).

We had previously listed a 20-pack of the same product, that is now out of stock.

Note that this medicine needs to be supplied under section 29 of the Medicines Act. The other listed brand, Calcit, is also a section 29 medicine.

Advice for Pharmacies

New listing from 1 February 2022. This listing will not appear in the Online Schedule until....

  • Chemical: Calcium lactate gluconate with calcium carbonate
  • Presentation: Tab eff 2.94 g with calcium carbonate 0.3 g (500 mg elemental) 
  • Pharmacode: 2631695
  • Brand: Calcium-Sandoz Forte
  • Pack size: 100
  • Subsidy and price (ex-man, ex-GST): $260.00

Note: This Pharmacode/pack size has section 29 and wastage applied to it.

The subsidy by endorsement that applies to the 20 tab pack size, also applies to the 100 tab pack size.

RxOne users: the new listings will be automatically updated by RxOne. If for some unforeseen circumstance it does not happen, please refer to the e-Noticeboard on the RxOne Home Screen for instructions.

TONIQ users: the new listings will automatically be updated in Toniq medicine databases from the effective date.

Please note that Ministry of Health Sector Operations Group will be unable to process claims for February 2022 dispensing of the above listings. Pharmacies can either hold these claims until March 2022 OR reclaim them in March 2022 when they are rejected for payment in February 2022 claims.

Resupply date

Link Pharmaceuticals (the supplier) does not yet have a resupply date for Calcit brand.

Who to contact

If you have questions about the supply of this product, contact Link Pharmaceuticals:

If you have a question about funding, email enquiry@pharmac.govt.nz